Cardiovascular Disease Doctors in Johnstown, PA Accepting Medicare

6 Cardiovascular Disease doctors found. Showing 1 - 6

Samir A Hadeed, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 374 Theatre Dr, Johnstown, PA 15904 Phone: 814-619-4587    Fax: 814-254-4154

Krishna M Bhat, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Tech Park Dr, Johnstown, PA 15901 Phone: 814-475-8600    Fax: 814-475-8666

Muhammad Hamza Saad Shaukat, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: Conemaugh Medical Park, One Tech Drive, Suite 2100, Johnstown, PA 15901 Phone: 814-475-8600    Fax: 814-475-8666

William E Smeal, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Tech Park Dr, Johnstown, PA 15901 Phone: 814-534-3850    Fax: 814-534-3392

Jude Arnold Mugerwa, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Tech Park Dr, Johnstown, PA 15901 Phone: 814-534-3850    Fax: 814-534-3392

Dr. Cyril Nathaniel, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1015 Franklin St, Wessel Building Level D, Johnstown, PA 15905 Phone: 814-534-5042

News Archive

Primary sclerosing cholangitis: Therapy with synthetic bile acid acts directly on the immune system

Primary Sclerosing Cholangitis (PSC) is a rare, chronic inflammatory disease of the bile ducts and is difficult to treat. Studies conducted by the Division of Gastroenterology and Hepatology at MedUni Wien under the guidance of Michael Trauner (Department of Internal Medicine III) were able to show positive effects from the administration of synthetically produced bile acids and bile acid receptor agonists.

NXT Nutritionals Holdings secures $2.35M financing

NXT Nutritionals Holdings, Inc., developer and marketer of SUSTA™ Natural Sweetener, the great tasting, all-natural, healthier sweetener, announced today that the Company has secured $2.35 million in financing through a private placement offering (the "Offering"). Proceeds from the Offering will be used for general corporate purposes and to fund further development and marketing of its SUSTA™ products.

World's first Cesium-131 lung implants performed

IsoRay, Inc. announced today that starting on August 12, 2009, Dr. Bhupesh Parashar from the Department of Radiation Oncology, and Dr. Nasser Altorki of the Department of Cardiothoracic Surgery at Weill Cornell Medical Center performed the world's first Cesium-131 lung implants.

Statins and beta blockers may reduce heart attack risk

For patients with undiagnosed heart disease, taking a statin or beta blocker could mean the difference between experiencing mild chest pain, or having a full-blown heart attack as a first symptom. That's the finding of a Kaiser Permanente study in the February 21 issue of the Annals of Internal Medicine.

Read more Medical News

› Verified 7 days ago